CDK2-IN-29
CDK2-IN-29 (Compound 13q) is an inhibitor for cyclin-dependent kinase (CDK), with IC50 of 96 nM and 360 nM, for CDK 2 and CDK 4, respectively[1].
Product Specifications
CAS Number
247149-58-2
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk2-in-29.html
Smiles
O=C1C2=C(C3=NNC(C4CCCCC4)=C13)C=CC=C2NC(CN5CCC(CC5)CN)=O
Molecular Formula
C24H31N5O2
Molecular Weight
421.54
References & Citations
[1]Yue EW, et al., Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3 (1,2) . J Med Chem. 2002 Nov 21;45 (24) :5233-48.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2; CDK4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2903062-01 20 µg
Recombinant Acidithiobacillus ferrooxidans ATP synthase subunit b (atpF)
Sign In for Pricing
View Details orb2903062-02 100 µg
Recombinant Acidithiobacillus ferrooxidans ATP synthase subunit b (atpF)
Sign In for Pricing
View Details